KRTCAP2

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 · Q8N6L1 · KRTCAP2 on Sugi Atlas →

0 patent compounds predicted against KRTCAP2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to KRTCAP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer PHASE2COMPLETED
Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis PHASE1/PHASE2ACTIVE_NOT_RECRUITING
24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG PHASE2COMPLETED
GD2/CD70 Bi-specific CAR-T Cell Therapy PHASE1/PHASE2RECRUITING
Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer PHASE1COMPLETED
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases PHASE1COMPLETED
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer PHASE1UNKNOWN
Safety Study of MGAH22 in HER2-positive Carcinomas PHASE1COMPLETED
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) PHASE1RECRUITING
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation nanCOMPLETED
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma nanCOMPLETED
PKP2-ACM Natural History Study nanRECRUITING
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer nanCOMPLETED
Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E nanCOMPLETED
Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects nanUNKNOWN
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa nanUNKNOWN
Biomarkers of Lichen Sclerosus nanUNKNOWN
A Retrospective Study to Identify New Omics Biomarkers of Chronic/Persistent Low Back Pain nanCOMPLETED
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta nanRECRUITING
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer nanRECRUITING
Myoglobin Removal With CytoSorb in Rhabdomyolysis nanCOMPLETED
Evaluation of Different Serum Cartilage Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Subjects nanAVAILABLE
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes nanCOMPLETED
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results nanCOMPLETED
Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study nanRECRUITING
Early Check: Expanded Screening in Newborns nanENROLLING_BY_INVITATION
Biomarker for Hurler Disease (BioHurler) nanWITHDRAWN
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a KRTCAP2 binder may also engage these)

ProteinNameSimilarity
A6QQ59 1.000 A6QQ59 →
Q5RL79 1.000 Q5RL79 →
P86229 1.000 P86229 →
B2RZC9 1.000 B2RZC9 →
ERG28 Ergosterol biosynthetic protein 28 homolog 0.955 landscape →
Q9ERY9 0.950 Q9ERY9 →
Q5R589 0.946 Q5R589 →
A6NI61 0.941 A6NI61 →
D0Q0Y7 0.939 D0Q0Y7 →
Q8TD22 0.938 Q8TD22 →
Q925N0 0.930 Q925N0 →
Q8CFD0 0.930 Q8CFD0 →
Q9H6U8 0.929 Q9H6U8 →
O95406 0.927 O95406 →
TECR Very-long-chain enoyl-CoA reductase 0.926 landscape →
Q8VDI9 0.926 Q8VDI9 →
Q5RDB5 0.926 Q5RDB5 →
Q5BIN6 0.925 Q5BIN6 →
Q13888 0.925 Q13888 →
Q8TBE1 0.925 Q8TBE1 →
Q6ZWS4 0.925 Q6ZWS4 →
Q5RB59 0.925 Q5RB59 →
Q6P1K8 0.924 Q6P1K8 →
Q2TBV5 0.924 Q2TBV5 →
Q9CY27 0.923 Q9CY27 →
Q3KNM2 0.923 Q3KNM2 →
Q0X0A5 0.923 Q0X0A5 →
O35372 0.923 O35372 →
B2KI79 0.922 B2KI79 →
PAICS Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase 0.922 landscape →